Clinical presentation, hematologic characteristics and survival outcome
of childhood leukemia with musculoskeletal involvement: A 42-year
experience from a single tertiary center in Thailand
Abstract
Abstract Background: Childhood leukemia with musculoskeletal (MSK)
involvement mimics various conditions, which consequently leads to
diagnostic delays. The clinical implication of MSK involvement in this
disease on survival outcomes is inconclusive. This study aimed to
compare characteristics and survival outcomes between MSK and non-MSK
involvement in childhood leukemia. Methods: The medical records of
children newly diagnosed with acute leukemia aged under 15 years were
retrospectively reviewed. Two-to-one nearest-neighbor propensity
score-matching was performed to obtain matched groups with and without
MSK involvement. The Kaplan-Meier method and log-rank test were then
used to assess the effect of MSK involvement on survival outcomes.
Results: Of 1042 childhood leukemia cases, 81 (7.8%) children had MSK
involvement at initial presentation. MSK involvement was more likely in
children with acute lymphoblastic leukemia than acute myeloid leukemia
(p <0.05). Hematologic abnormalities were less frequent in the
MSK involvement group (p <0.05). The absence of peripheral
blast cells was significantly higher in the MSK involvement group
(17.3% vs 9.6%, p = 0.04). Normal complete blood counts with absence
of peripheral blast cells were found 2.5% of the children with MSK
involvement. By propensity score-matching for comparable risk groups of
children with and without MSK involvement, the 5-year overall survival
was not significantly different (48.2% vs 57.4%, respectively, p =
0.22), nor was event-free survival (43.3% vs 51.8%, respectively, p =
0.31). Conclusion: Childhood leukemia with MSK involvement had the
characteristics of minimal or absent hematologic abnormalities and
peripheral blast counts.